Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Cell-autonomous Hedgehog signaling controls Th17 polarization and pathogenicity

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. cyCombine allows for robust integration of single-cell cytometry datasets within and across technologies

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Serum metabolome associated with severity of acute traumatic brain injury

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Structural basis for PoxtA-mediated resistance to phenicol and oxazolidinone antibiotics

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  • Joachim Hanna
  • Flavio Beke
  • Louise M O'Brien
  • Chrysa Kapeni
  • Hung-Chang Chen
  • Valentina Carbonaro
  • Alexander B Kim
  • Kamal Kishore
  • Timon E Adolph
  • Mikkel-Ole Skjoedt
  • Karsten Skjoedt
  • Marc de la Roche
  • Maike de la Roche
Vis graf over relationer

Th17 cells are key drivers of autoimmune disease. However, the signaling pathways regulating Th17 polarization are poorly understood. Hedgehog signaling regulates cell fate decisions during embryogenesis and adult tissue patterning. Here we find that cell-autonomous Hedgehog signaling, independent of exogenous ligands, selectively drives the polarization of Th17 cells but not other T helper cell subsets. We show that endogenous Hedgehog ligand, Ihh, signals to activate both canonical and non-canonical Hedgehog pathways through Gli3 and AMPK. We demonstrate that Hedgehog pathway inhibition with either the clinically-approved small molecule inhibitor vismodegib or genetic ablation of Ihh in CD4+ T cells greatly diminishes disease severity in two mouse models of intestinal inflammation. We confirm that Hedgehog pathway expression is upregulated in tissue from human ulcerative colitis patients and correlates with Th17 marker expression. This work implicates Hedgehog signaling in Th17 polarization and intestinal immunopathology and indicates the potential therapeutic use of Hedgehog inhibitors in the treatment of inflammatory bowel disease.

OriginalsprogEngelsk
Artikelnummer4075
TidsskriftNature Communications
Vol/bind13
Udgave nummer1
Sider (fra-til)4075
ISSN2041-1722
DOI
StatusUdgivet - 14 jul. 2022

Bibliografisk note

© 2022. The Author(s).

ID: 79467490